Related Experiment Video
Updated: Jan 21, 2026

Modeling Spontaneous Metastatic Renal Cell Carcinoma mRCC in Mice Following Nephrectomy
Published on: April 29, 2014
A rare presentation of spontaneous atheroembolic renal disease: A case report
Paramarajan Piranavan1, Ashna Rajan2, Vishal Jindal2
1Department of Medicine, Saint Vincent Hospital, Worcester, MA 01608, United States. paramaraja.piranvan@stivincenthospital.com.
Insights
Atheroembolic renal disease (AERD), caused by cholesterol crystal emboli, can be treated with steroids. This case report highlights a patient with AERD who showed significant improvement in renal function after steroid therapy.
Area of Science:
- Nephrology
- Cardiovascular Medicine
- Rheumatology
Background:
- Atheroembolic renal disease (AERD) results from cholesterol crystal emboli obstructing renal arteries, often linked to systemic atherosclerosis.
- AERD typically presents as isolated renal disease or part of a broader systemic atheroembolic condition.
Observation:
- A 62-year-old woman with hypertension and CKD experienced rapidly declining renal function.
- She presented with edema, dyspnea, and epistaxis, with positive c-ANCA serology.
- Imaging revealed diffuse atherosclerosis; initial suspicion was c-ANCA-associated vasculitis.
Findings:
- Renal biopsy confirmed Atheroembolic renal disease (AERD).
- Despite initial misdiagnosis of vasculitis, steroid treatment led to renal function improvement.
- The patient's renal function continued to improve post-discharge on oral prednisone.
Implications:
- This case underscores the importance of suspecting spontaneous AERD in patients with atherosclerosis and ANCA positivity.
- While no definitive treatment exists, steroids and statins warrant further investigation for AERD management.
- Early diagnosis and appropriate intervention, even if initially misdirected, can impact patient outcomes in complex renal diseases.
Background:
Atheroembolic renal disease (AERD) is caused by occlusion of the small renal arteries from embolized cholesterol crystals arising from ulcerated atherosclerotic plaques. This usually manifests as isolated renal disease or involvement from systemic atheroembolic disease. Here we report a case of AERD that responded well to steroid therapy.
Case Summary:
A 62-year-old woman with a history of hypertension and stage IIIa chronic kidney disease was referred for rapidly worsening renal function over a 4-mo period. She complained of swollen legs, dyspnea on exertion, and two episodes of epistaxis about a month prior to admission. She reported no history of invasive vascular procedures, use of radio contrast agents, or treatment with anticoagulants or thrombolytic agents. Urinalysis showed a few red blood cells and granular casts. Serology was positive for cytoplasmic antineutrophil cytoplasmic antibodies (c-ANCA). Non-contrast-enhanced computed tomography of the chest, abdomen, and pelvis showed diffuse atherosclerotic changes in the aortic arch. Thus, c-ANCA-associated vasculitis was suspected, and the patient was started on pulse intravenous methylprednisolone. Her renal biopsy showed evidence of AERD. She was discharged with oral prednisone, and her renal function continued to improve during the initial follow-up.
Conclusion:
In cases of non-vasculitis-associated ANCA, a high degree of clinical suspicion is required to pursue the diagnosis of spontaneous AERD in patients with clinical or radiological evidence of atherosclerotic burden. Although no specific treatment is available, the potential role of statins and steroids requires exploration.
Related Concept Videos
Spontaneity
Self-Presentation
Self-Presentation: Self-Monitoring and Self-Handicapping
Strategies of Self-Presentation I: Strategic Self-Presentation
Processes of Self-Presentation
Strategies of Self-Presentation II: Self-Verification

